1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow CD19- BCMA CAR-T cells: new trials by email Literature Review of CD19- BCMA CAR-T cells trials Research Report on CD19- BCMA CAR-T cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) CD19- BCMA CAR-T cells - Systemic Lupus Erythematosus, Lupus Nephritis | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 75 | 2024-07-10 | 2024-10-15 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Autoimmune Diseases (1) · Granulomatosis with Polyangiitis (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Microscopic Polyangiitis (1) · Myositis (1) · Scleroderma, Systemic (1) · Sjogren's Syndrome (1)
Essen Biotech (1)
China (1)